[go: up one dir, main page]

MX2023008768A - Composicion probiotica para el tratamiento de la enfermedad por coronavirus de 2019 (covid-19). - Google Patents

Composicion probiotica para el tratamiento de la enfermedad por coronavirus de 2019 (covid-19).

Info

Publication number
MX2023008768A
MX2023008768A MX2023008768A MX2023008768A MX2023008768A MX 2023008768 A MX2023008768 A MX 2023008768A MX 2023008768 A MX2023008768 A MX 2023008768A MX 2023008768 A MX2023008768 A MX 2023008768A MX 2023008768 A MX2023008768 A MX 2023008768A
Authority
MX
Mexico
Prior art keywords
probiotic composition
covid
cect
treatment
lactobacillus plantarum
Prior art date
Application number
MX2023008768A
Other languages
English (en)
Inventor
Mazo Jordi Espadaler
Larrosa Ariana Salavert
Brugué Sergi Audivert
Sierra Miquel Àngel Bonachera
Original Assignee
Ab Biotics Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Biotics Sa filed Critical Ab Biotics Sa
Publication of MX2023008768A publication Critical patent/MX2023008768A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/41—Pediococcus
    • A23V2400/413—Acidilactici
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se proporciona una composición probiótica que comprende Lactobacillus plantarum CECT 30292, Lactobacillus plantarum CECT 7484, Lactobacillus plantarum CECT 7485, y Pediococcus acidilactici CECT 7483. La composición probiótica es útil en el tratamiento, prevención, o mejora del COVID-19, y otras enfermedades infecciosas. También es útil para mejorar la respuesta inmunitaria.
MX2023008768A 2021-02-12 2022-02-11 Composicion probiotica para el tratamiento de la enfermedad por coronavirus de 2019 (covid-19). MX2023008768A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2021/053539 WO2022171304A1 (en) 2021-02-12 2021-02-12 Probiotic composition for the treatment of covid-19
PCT/EP2022/053332 WO2022171779A1 (en) 2021-02-12 2022-02-11 Probiotic composition for the treatment of covid-19

Publications (1)

Publication Number Publication Date
MX2023008768A true MX2023008768A (es) 2023-08-02

Family

ID=74672280

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023008768A MX2023008768A (es) 2021-02-12 2022-02-11 Composicion probiotica para el tratamiento de la enfermedad por coronavirus de 2019 (covid-19).

Country Status (9)

Country Link
US (1) US20240226199A1 (es)
EP (1) EP4291214A1 (es)
JP (1) JP2024507736A (es)
KR (1) KR20240000456A (es)
CN (1) CN117083069A (es)
AU (1) AU2022219245A1 (es)
CA (1) CA3206237A1 (es)
MX (1) MX2023008768A (es)
WO (2) WO2022171304A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115737690B (zh) * 2022-11-11 2024-04-19 重庆医科大学 约氏乳杆菌在制备用于缓解急性呼吸窘迫综合征的药物中的应用
TWI858748B (zh) * 2023-05-31 2024-10-11 創百股份有限公司 益生菌與後生元的組合在改善SARS-CoV-2感染相關的病況上的用途
WO2025206253A1 (ja) * 2024-03-28 2025-10-02 株式会社カネカ プロバイオティクスを含有する自己乳化製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007834A1 (en) * 2003-07-23 2005-01-27 Probionic Corp. Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus
KR100872910B1 (ko) * 2007-10-25 2008-12-10 두두원발효(주) 김치유산균으로 발효한 콩 요구르트를 유효성분으로함유하는 조류독감, 독감 및 사스의 호흡기성 급성전염질환바이러스에 대한 항바이러스 조성물
KR101104397B1 (ko) * 2008-11-25 2012-01-16 한국생명공학연구원 유산균 발효유 필터액을 함유하는 바이러스 감염 질환 예방또는 치료용 조성물
RU2563525C2 (ru) 2010-01-28 2015-09-20 Аб-Биотикс С.А. Пробиотическая композиция для применения в лечении воспаления кишечника
AR119653A1 (es) * 2018-07-13 2022-01-05 Cj Cheiljedang Corp Cepa cjlp475 de lactobacillus plantarum que tiene efectos antivirales e inmunomoduladores y una composición que comprende la misma

Also Published As

Publication number Publication date
CA3206237A1 (en) 2022-08-18
AU2022219245A1 (en) 2023-08-31
WO2022171304A1 (en) 2022-08-18
JP2024507736A (ja) 2024-02-21
KR20240000456A (ko) 2024-01-02
EP4291214A1 (en) 2023-12-20
WO2022171779A1 (en) 2022-08-18
CN117083069A (zh) 2023-11-17
US20240226199A1 (en) 2024-07-11

Similar Documents

Publication Publication Date Title
MX2023008768A (es) Composicion probiotica para el tratamiento de la enfermedad por coronavirus de 2019 (covid-19).
FI20001460A0 (fi) Probiootit atooppisten sairauksien primaariseen ehkäisyyn
TR200101699T2 (tr) Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması
SE0400355D0 (sv) New synbiotec use
ZA202109421B (en) Compositions comprising a bacterial strain lactobacillus paracasei and hyaluronic acid and the use thereof for the treatment of the skin
PH12019501629A1 (en) Probiotic compositions and uses therof
SE0103127D0 (sv) Lactic acid producing bacteria for use as probiotic organisms in the human vagina
MY197900A (en) Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety
WO2018013583A3 (en) Medicinal vaginal lactobacillus cocktail
DE602004019255D1 (de) Probiotische Zusammensetzung
MY162344A (en) Probiotic composition for use in the treatment of bowel inflammation
PH12018550110B1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
MY193275A (en) Use of probiotics in the treatment and/or prevention of psoriasis
SA519400920B1 (ar) استخدام المعززات الحيوية في علاج و/أو الوقاية من التهاب الجلد التأتبي
MY209530A (en) Methods and compositions for the treatment of hair loss
DE60214029D1 (de) Milchsäurebakterien und deren verwendungen zur behandlung von und vorbeugung gegen krebs
MX2025000629A (es) Cepas de lactobacillus salivarius y usos de las mismas
ZA202110476B (en) Composition with antibacterial and re-epithelializing action including probiotics
MX2024004449A (es) Composicion probiotica para la modulacion del microbioma intestinal.
RS66940B1 (sr) Soj lactobacillus salivarus i njegova upotreba u prevenciji i lečenju dijareje nakon odbijanja kod prasadi
WO2007015132A3 (en) Use of specific lactic bacteria for the preparation of immunomodulating compositions
MX2020013860A (es) Composiciones probioticas y sus usos.
EP4450611A3 (en) Probiotic composition and uses thereof against candida infections
MY128704A (en) Panty liner
TW200611973A (en) Novel microorganism strain GM-090 of lactobacillus fermentum and its use for stimulating IFN-γ secretion and/or treating allergy